JP2023086734A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023086734A5 JP2023086734A5 JP2023051617A JP2023051617A JP2023086734A5 JP 2023086734 A5 JP2023086734 A5 JP 2023086734A5 JP 2023051617 A JP2023051617 A JP 2023051617A JP 2023051617 A JP2023051617 A JP 2023051617A JP 2023086734 A5 JP2023086734 A5 JP 2023086734A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nucleotide sequence
- composition
- fragment
- sequence identity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002773 nucleotide Substances 0.000 claims 30
- 125000003729 nucleotide group Chemical group 0.000 claims 30
- 239000012634 fragment Substances 0.000 claims 26
- 125000003275 alpha amino acid group Chemical group 0.000 claims 13
- 201000010099 disease Diseases 0.000 claims 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 9
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 238000003776 cleavage reaction Methods 0.000 claims 3
- 230000007017 scission Effects 0.000 claims 3
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
- 208000024908 graft versus host disease Diseases 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 206010057248 Cell death Diseases 0.000 claims 1
- 108090001005 Interleukin-6 Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 206010040047 Sepsis Diseases 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000009089 cytolysis Effects 0.000 claims 1
- 239000013604 expression vector Substances 0.000 claims 1
- 208000021760 high fever Diseases 0.000 claims 1
- 208000015325 multicentric Castleman disease Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025077437A JP2025147175A (ja) | 2016-05-05 | 2025-05-07 | Ｉｌ－６及びｃｄ１２６を標的とするｄｎａモノクローナル抗体 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662332377P | 2016-05-05 | 2016-05-05 | |
| US62/332,377 | 2016-05-05 | ||
| PCT/US2017/031193 WO2017192933A1 (en) | 2016-05-05 | 2017-05-05 | Dna monoclonal antibodies targeting il-6 and cd126 |
| JP2019510567A JP7311113B2 (ja) | 2016-05-05 | 2017-05-05 | Ｉｌ－６及びｃｄ１２６を標的とするｄｎａモノクローナル抗体 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019510567A Division JP7311113B2 (ja) | 2016-05-05 | 2017-05-05 | Ｉｌ－６及びｃｄ１２６を標的とするｄｎａモノクローナル抗体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025077437A Division JP2025147175A (ja) | 2016-05-05 | 2025-05-07 | Ｉｌ－６及びｃｄ１２６を標的とするｄｎａモノクローナル抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023086734A JP2023086734A (ja) | 2023-06-22 |
| JP2023086734A5 true JP2023086734A5 (https=) | 2023-09-04 |
Family
ID=60203626
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019510567A Active JP7311113B2 (ja) | 2016-05-05 | 2017-05-05 | Ｉｌ－６及びｃｄ１２６を標的とするｄｎａモノクローナル抗体 |
| JP2023051617A Pending JP2023086734A (ja) | 2016-05-05 | 2023-03-28 | Ｉｌ－６及びｃｄ１２６を標的とするｄｎａモノクローナル抗体 |
| JP2025077437A Pending JP2025147175A (ja) | 2016-05-05 | 2025-05-07 | Ｉｌ－６及びｃｄ１２６を標的とするｄｎａモノクローナル抗体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019510567A Active JP7311113B2 (ja) | 2016-05-05 | 2017-05-05 | Ｉｌ－６及びｃｄ１２６を標的とするｄｎａモノクローナル抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025077437A Pending JP2025147175A (ja) | 2016-05-05 | 2025-05-07 | Ｉｌ－６及びｃｄ１２６を標的とするｄｎａモノクローナル抗体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20190192692A1 (https=) |
| EP (1) | EP3452106A4 (https=) |
| JP (3) | JP7311113B2 (https=) |
| KR (3) | KR20190031439A (https=) |
| CN (1) | CN109789224A (https=) |
| AU (2) | AU2017261292B2 (https=) |
| BR (1) | BR112018072697A2 (https=) |
| CA (1) | CA3023089A1 (https=) |
| EA (1) | EA201892524A1 (https=) |
| MX (2) | MX2018013523A (https=) |
| SG (2) | SG10202011023YA (https=) |
| WO (1) | WO2017192933A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110167584B (zh) * | 2016-11-07 | 2024-06-07 | 威斯塔解剖学和生物学研究所 | 用于针对莱姆病的dna抗体构建体 |
| KR102635888B1 (ko) | 2019-03-19 | 2024-02-15 | 엘지전자 주식회사 | 공기청정기 |
| JP2024504614A (ja) * | 2021-01-14 | 2024-02-01 | トランスレイト バイオ， インコーポレイテッド | ｍＲＮＡがコードする抗体を送達する方法および組成物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0214168B8 (pt) * | 2001-11-14 | 2021-05-25 | Centocor Inc | anticorpos anti-il-6, moléculas de ácido nucleico codificando os mesmos, vetores compreendendo as referidas moléculas, composições e formulações compreendendo os referidos anticorpos, bem como métodos de produção dos mesmos |
| PE20061324A1 (es) * | 2005-04-29 | 2007-01-15 | Centocor Inc | Anticuerpos anti-il-6, composiciones, metodos y usos |
| EP2336181A1 (en) * | 2005-12-09 | 2011-06-22 | UCB Pharma, S.A. | Antibody molecules having specificity for human IL-6 |
| MX2009001110A (es) * | 2006-08-03 | 2009-05-11 | Vaccinex Inc | Anticuerpos monoclonales anti-il-6 y usos de los mismos. |
| WO2009140348A2 (en) | 2008-05-13 | 2009-11-19 | Novimmune Sa | Anti-il-6/il-6r antibodies and methods of use thereof |
| WO2011084714A2 (en) | 2009-12-17 | 2011-07-14 | Biogen Idec Ma Inc. | STABILIZED ANTI-TNF-ALPHA scFv MOLECULES OR ANTI-TWEAK scFv MOLECULES AND USES THEREOF |
| US9304134B2 (en) | 2010-11-23 | 2016-04-05 | Alderbio Holdings Llc | Anti-IL-6 antibodies for the treatment of anemia |
| CA2889723A1 (en) * | 2012-12-13 | 2014-06-19 | The Trustees Of The University Of Pennsylvania | Dna antibody constructs and method of using same |
| IL312865B2 (en) | 2013-09-11 | 2025-06-01 | Eagle Biologics Inc | Liquid protein formulations containing viscosity-lowering agents |
| WO2015054293A1 (en) * | 2013-10-07 | 2015-04-16 | Alder Biopharmaceuticals, Inc. | Anti-il-6 antibodies for the treatment of psoriatic arthritis |
-
2017
- 2017-05-05 KR KR1020187035166A patent/KR20190031439A/ko not_active Ceased
- 2017-05-05 EP EP17793405.6A patent/EP3452106A4/en active Pending
- 2017-05-05 KR KR1020257000876A patent/KR20250011241A/ko active Pending
- 2017-05-05 JP JP2019510567A patent/JP7311113B2/ja active Active
- 2017-05-05 BR BR112018072697-4A patent/BR112018072697A2/pt unknown
- 2017-05-05 CA CA3023089A patent/CA3023089A1/en active Pending
- 2017-05-05 MX MX2018013523A patent/MX2018013523A/es unknown
- 2017-05-05 KR KR1020237013950A patent/KR20230058733A/ko not_active Ceased
- 2017-05-05 SG SG10202011023YA patent/SG10202011023YA/en unknown
- 2017-05-05 AU AU2017261292A patent/AU2017261292B2/en active Active
- 2017-05-05 CN CN201780041454.5A patent/CN109789224A/zh active Pending
- 2017-05-05 EA EA201892524A patent/EA201892524A1/ru unknown
- 2017-05-05 US US16/098,918 patent/US20190192692A1/en active Pending
- 2017-05-05 SG SG11201809786TA patent/SG11201809786TA/en unknown
- 2017-05-05 WO PCT/US2017/031193 patent/WO2017192933A1/en not_active Ceased
-
2018
- 2018-11-05 MX MX2025009846A patent/MX2025009846A/es unknown
-
2023
- 2023-03-28 JP JP2023051617A patent/JP2023086734A/ja active Pending
-
2024
- 2024-05-10 AU AU2024203109A patent/AU2024203109A1/en active Pending
-
2025
- 2025-05-07 JP JP2025077437A patent/JP2025147175A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023086734A5 (https=) | ||
| JP2022105138A5 (https=) | ||
| JP2019522490A5 (https=) | ||
| CY1118037T1 (el) | Αντισωματα εναντι του αβητα και h χρηση τους | |
| JP2008525033A5 (https=) | ||
| JP2021524270A5 (https=) | ||
| RU2012118636A (ru) | Молекула, специфически связывающаяся с rsv | |
| JP2021524275A5 (https=) | ||
| MX347175B (es) | Anticuerpos igm humanos con la capacidad de inducir remielinacion, y usos diagnosticos y terapeuticos de los mismos particularmente en el sistema nervioso central. | |
| JPWO2020059847A5 (https=) | ||
| JP2023171909A5 (https=) | ||
| JP2020518249A5 (https=) | ||
| JP2025081549A5 (https=) | ||
| RU2002133470A (ru) | Специфичные в отношении вируса бешенства нейтрализующие моноклональные антитела человека и нуклеиновые кислоты, и связанные с ними способы | |
| CN117866905B (zh) | 基于纳米抗体基因修饰的干细胞及其制备方法和产品 | |
| WO2023009028A1 (ru) | Однодоменное антитело и его модификации, специфически связывающиеся с rbd s белка вируса sars-cov-2 | |
| RU2004108115A (ru) | Рекомбинантные антитела и композиции, а также способы их создания и использования | |
| ES2358118T3 (es) | Procedimiento para la obtención de anticuerpos humanos que neutralizan la actividad biológica de una citoquina humana. | |
| Kalinke et al. | Monovalent single‐chain Fv fragments and bivalent miniantibodies bound to vesicular stomatitis virus protect against lethal infection | |
| JP2005512518A5 (https=) | ||
| JP2025504537A (ja) | Ｈｂｖ感染及び関連疾患の治療のためのエピトープペプチド及び抗体 | |
| JPWO2021158623A5 (https=) | ||
| CN117860786B (zh) | 基因修饰间充质干细胞在多种疾病中的制药用途和诊断用途 | |
| CN104356210A (zh) | 与凡纳滨对虾Rab7具有结合活性的VP28蛋白片段的高效表达与应用 | |
| JPWO2022190018A5 (https=) |